Compare · MDLN vs SSKN
MDLN vs SSKN
Side-by-side comparison of Medline Inc. (MDLN) and Strata Skin Sciences Inc. (SSKN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and SSKN operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $44.15B, about 901.8x SSKN ($49.0M).
- Over the past year, MDLN is down 17.4% and SSKN is down 91.9% - MDLN leads by 74.5 points.
- MDLN has been more active in the news (20 items in the past 4 weeks vs 1 for SSKN).
- MDLN has more recent analyst coverage (25 ratings vs 0 for SSKN).
- Company
- Medline Inc.
- Strata Skin Sciences Inc.
- Price
- $33.65+0.15%
- $0.19-38.08%
- Market cap
- $44.15B
- $49.0M
- 1M return
- -19.90%
- +0.00%
- 1Y return
- -17.42%
- -91.88%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2005
- News (4w)
- 20
- 1
- Recent ratings
- 25
- 0
Strata Skin Sciences Inc.
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. Its products include XTRAC excimer laser and VTRAC lamp systems that are used for the treatment of psoriasis, vitiligo, atopic dermatitis, eczema, and other skin disorders. The company distributes its products internationally through distributors, and domestically directly to physicians. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.
Latest MDLN
- Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement
- Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)
- Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)
- Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Large owner Bcp 8 Holdings Mozart Manager L.L.C. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)
- Medline's Prime Vendor model expands outside the United States
- Medline Inc. announces closing of upsized secondary offering of Class A common stock
- Medline announces participation in upcoming investor conferences
- MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
- Large owner Bx Mozart Ml-1 Holdco L.P. converted options into 11,348,698 shares and disposed of 11,348,698 units of Class B Common Stock (SEC Form 4)
Latest SSKN
- New Peer-Reviewed Publication Confirms Unprecedented Response Rates for STRATA's Excimer Laser Combined with JAK Inhibitors in Pediatric Vitiligo
- SEC Form 10-K filed by Strata Skin Sciences Inc.
- SEC Form EFFECT filed by Strata Skin Sciences Inc.
- SEC Form EFFECT filed by Strata Skin Sciences Inc.
- SEC Form EFFECT filed by Strata Skin Sciences Inc.
- SEC Form 15-12G filed by Strata Skin Sciences Inc.
- SEC Form POS AM filed by Strata Skin Sciences Inc.
- SEC Form POS AM filed by Strata Skin Sciences Inc.
- SEC Form S-8 POS filed by Strata Skin Sciences Inc.
- SEC Form POS AM filed by Strata Skin Sciences Inc.